Institut Jules Bordet - Jules Bordet Instituut

Informations Médicales

Accueil Plan du site Recherche par Mot-clef ou Profil Contact News à l'Institut Bordet Actualités Médicales

Séminaires, Conférences, Cours ...

Belgian Symposium on the Integration of Molecular Biology Advances into Oncology Clinical Practice

 

   

 

7th Belgian Symposium on the
Integration of Molecular Biology Advances into Oncology Clinical Practice

 

 

Friday November 22th, 2013
and Saturday November 23th, 2013

 

Organizing Committee:

Institut Jules Bordet

A. AWADA / J. KERGER
P. AFTIMOS

M. PICCART-GEBHART

BSMO

J. DE GRÈVE / L. DIRIX

R. PARIDAENS

J.P. MACHIELS

 

Location: Hotel Golden Tulip, Bessenveldstraat 15, Diegem, Belgium

 

 
Friday 22 NOVEMBER 2013 afternoon
13.30 - 14.00 Arrival – coffee and tea
14.00 - 14.05

Welcome

A. Awada (Jules Bordet, Belgium) - J. De Grève (VUB, Belgium)

14.05 – 14.30

Chair: L. Dirix

Precision oncology : From pathology to genomics

P. Pauwels (UZA)

14.30 – 16.00

Chair: A. Awada

Cancer Immunotherapy : a revisited approach

 

- Checkpoints inhibitors (20’)

P. Coulie (UCL)

- Antibody – Drug conjugates (20’)

L Dirix (GZA)

- Oncolytic viruses (20’)

A Melcher (Univeristy of Leeds – UK)

- Vaccines (20’)

TBC

- Perspectives (10’)

L. Buisseret (IJB)

16.00 – 16.30

Coffee Break

16.30 – 16.50

Chair: J.P. Machiels

Rethinking tumor response evaluation of targeted agents : when and how to resist RECIST (20’)

J. Bogaerts (EORTC)

16.50 – 17.15

Chair: J. Klastersky

Supportive care of targeted therapies toxicities: are we well prepared ? (25’)

N. Penel (O. Lambret, Lille)

17.15 – 18.30

Chairs: H. Wildiers, J. De Grève

Genomic profiling of breast cancer: Ready for use?

 

- Overview of available plattforms (30’)

J. Bartlett (Canada)

- Genomic profiling: Pronostic and/or predictive value? (30’)

H.A. Azim (IJB)

- Panel discussion

 

Saturday 23 NOVEMBER 2013 Morning
8.00 – 8.30 Arrival – coffee and tea

8.30 – 9.00

Chair: A. Awada

New Hallmarks of cancer : Metabolism and inflammation as cancer targets (30’)

TBD

9.00 – 9.30

Chair: J. De Grève

Genomic Medicine in human solid cancer : Prospects and challenges (30’)

J. Rodon (Val D’hebron – Spain)

9.30-10.30

Chair : M. Piccart

Cancer Genotype – directed therapy

 

- Breast cancer (20’)

F. André (I. Gustave Roussy-Paris)

- NSCLC (non-squamous) (20’)

G. Berchem (Luxembourg)

- Other solid tumors (20’)

P. Aftimos (IJB)

10.30 – 11.00 Coffee Break

11.00 – 12.20

Chair: R. Paridaens

Molecular alterations and therapeutic perspectives

 

- Gastro-intestinal cancers (20’)

S. Tejpar (KUL)

- Urothelial cancers (20’)

J.P. Machiels (UCL)

- Gynecological cancers (20’)

J. Kerger (IJB)

- NSCLC (squamous) (20’)

J. de Grève (UZ)

12.20 – 12.30

Closing remarks followed by a light lunch

R. Paridaens (KUL) - A. Awada (IJB)

 

Accreditation in Ethics for all attendees will be requested
For further information please contact Ms. Mariella Gonzalez : mariella.gonzalez@bordet.be

Registration form : click here

Program : click here

   

©2005, Institut Jules Bordet - 121 Boulevard de Waterloolaan, Bruxelles 1000 Brussel, telephone image+32 2 541 31 11